Provider
Agamree® (vamorolone), Emflaza® (deflazacort) - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025
Program effective Date: Feb 01, 2025